🌟 Exciting News from CMaT & ISCT! 🌟
We are thrilled to invite you to meet the CMaT and ISCT workforce development teams at the ISCT 2024 Conference in Vancouver next week! Come visit us at booth #222 to explore the pioneering workforce development training offered through our collaboration.
🔬 Special Feature: Linda Kippner from MC3M will be present to discuss our exclusive Hands-on Laboratory Bootcamp for Cell Therapy Biomanufacturing. Don’t miss this chance to gain insights directly from industry experts and learn how you can participate.
📅 Mark Your Calendar: The next bootcamp is scheduled for August at MC3M. This is a fantastic opportunity for professionals looking to enhance their skills in the rapidly evolving field of cell therapy.
Interested? Learn more and sign up here: Hands-on Laboratory Bootcamp for Cell Therapy
👉 Stop by, say hello, and discover how you can be part of shaping the future of biomanufacturing!
#ISCT2024 #CellTherapy #Biomanufacturing #WorkforceDevelopment #CMaT #ISCT #MC3M #Biotech #Innovation #CareerDevelopment
Recent Publications
- Wang B, Chen RQ, Roy K. Interfacing data science with cell therapy manufacturing; where we are and where we need to be. Cytotherapy 2024 DOI: 10.1016/j.jcyt.2024.03.011
- Liu Z, Wang B, Kanwar B, Wang K, Bowles-Welch A, Balakirsky S, Roy K, Zhang C, An in-situ localized cell density monitoring method for adherent cells in hollow fiber bioreactors, Sensors and Actuators B: Chemical, Volume 407, 2024, DOI: 10.1016/j.snb.2024.135467.
- Stevens HY, Jimenez AC, Wang B, Li Y, Selvam S, Bowles-Welch AC. Mesenchymal Stromal Cell (MSC) Functional Analysis—Macrophage Activation and Polarization Assays. Bio-protocol 2024 14(6): e4957. DOI: 10.21769/BioProtoc.4957.
- Li Y, Stevens HY, Sivaraman S, Porter LN, Hoffman AR, Gibb SL, Selvam S, Bowles-Welch AC. Streamlined Methods for Processing and Cryopreservation of Cell Therapy Products Using Automated Systems. Bio-protocol 2023 Dec 20;13(24):e4900. DOI: 10.21769/BioProtoc.4900.
News and Events
Georgia Tech to Build New $23 Million Research Center
Georgia Research Alliance and Georgia Tech sources also provided funding for a total investment of $23 million. The center also plans to seek funding from federal agencies, clinical research organizations and other sources.
New Cell Manufacturing Research Facility will Change Approaches to Disease Therapies
The vision of making affordable, high-quality cell-based therapies available to hundreds of thousands of patients worldwide moved closer to reality June 6 with the dedication of a new cell…
Stem Cell Factory Opens Door for Trials of Personalized Diabetes Treatment
In a step that could lead to a new diabetes treatment, several Boston-area hospitals have teamed up with the Harvard Stem Cell Institute and biotech Semma Therapeutics to make personalized cell-based therapies and organize clinical trials.
New Institute Aims to Help Bring Cell-based Medicines to Market
December 22, 2016
The Georgia Institute of Technology will play a key role in a new federally backed initiative to advance medications made from cells, such as vaccines…
Research Center Will Focus on Consistent Manufacturing Methods for Cell-Based Therapies
The work of the new Marcus Center for Therapeutic Cell Characterization and Manufacturing (MC3M) is expected to provide standardized production and quality testing of these living cells, similar to that which already exists for drug-based pharmaceuticals.
Inside the Effort to Bring Life-Saving Cell Therapies to the Masses
Doctors knew long before Owen Webb was born that they were racing against the clock to save his life.
New Georgia Tech Research Center Launched to Manufacture Living Cells for Cell-Based Therapies
A $15.7 million grant from the Atlanta-based Marcus Foundation has helped launch a new Georgia Institute of Technology research center that will develop processes and techniques for ensuring the consistent, low-cost, large-scale manufacture of…
Roy Discusses Cell Manufacturing at Georgia Tech
In this age of rapidly changing technology and global challenges, the question has become, “What’s next…
Consortium develops national roadmap for advanced cell manufacturing, showing the way to cell-based therapeutics.
Roy’s Roadmap Leads to the Vatican
Krishnendu Roy scanned the room, taking note of the people all around him in the Vatican, and thought, “what the heck am I doing here?”
Scaling Up Cell-Based Therapies
Georgia Tech, GRA and industry partners charting a path to large-scale manufacturing of cell-based therapeutics.
Roadmap for Advanced Cell Manufacturing /v n nvcnb Path to Cell-Based Therapeutics
An industry-driven consortium has developed a national roadmap designed to chart the path to large-scale manufacturing of cell-based therapeutics for use in a broad range of illnesses including…
Center Will Develop Consistent Manufacturing Processes for Cell-based Therapies
A $15.7 million grant from the Atlanta-based Marcus Foundation has helped launch a new Georgia Institute of Technology research center that will develop processes and techniques for ensuring the…